Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

39.65 -1.82 (-4.39%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Spruce Biosciences Inc (NASDAQ:SPRB) Reports Q3 2025 Results, Secures $50M Financing and Breakthrough Therapy Designation ↗

November 10, 2025

Spruce Biosciences reports Q3 2025 results, secures $50M financing and Breakthrough Therapy Designation for its lead drug candidate.

Via Chartmill

Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

November 10, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Traders are paying attention to the gapping stocks in Wednesday's session. ↗

October 08, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

SPRB Stock Hits 19-Month High Amid Trading Halts ↗

October 07, 2025

Via Stocktwits

Spruce Biosciences Stock Nearly Doubles Premarket: 'Pharma Bro' Martin Shkreli Sees 280% Upside ↗

October 07, 2025

Via Stocktwits

Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease ↗

October 06, 2025

Via Stocktwits

Spruce Biosciences Announces $50.0 Million Private Placement Financing

October 08, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Top stock movements in today's session. ↗

October 07, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 07, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

October 07, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

October 07, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 07, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 07, 2025

Via Benzinga

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗

October 07, 2025

Via Benzinga

Spruce Biosciences (SPRB) Stock Jumps 30% After Hours Following Red Hot Rally On Monday: Here's Why ↗

October 07, 2025

Spruce Biosciences shares soared after the FDA granted Breakthrough Therapy Designation to its lead treatment for Sanfilippo Syndrome Type B.

Via Benzinga

Why Spruce Biosciences Just Skyrocketed More Than 1,600% ↗

October 06, 2025

The company is working on a treatment for a rare, genetic disease.

Via Investor's Business Daily

Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge ↗

October 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 06, 2025

Via Benzinga

Spruce Biosciences Stock Is Soaring Today: Here's Why ↗

October 06, 2025

Shares of Spruce Biosciences, Inc. (NASDAQ: SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments.

Via Benzinga

US Stocks Mixed; Dow Falls 100 Points ↗

October 06, 2025

Via Benzinga

Topics Stocks

Wondering what's happening in today's pre-market session? ↗

October 06, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 06, 2025

Via Benzinga

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)

October 06, 2025

From Spruce Biosciences, Inc.

Via Business Wire

These stocks that are showing activity before the opening bell on Friday. ↗

October 03, 2025

Wondering what's happening in Friday's pre-market session? Find an overview in this article.

Via Chartmill

Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 15, 2025

Via Benzinga

Spruce Biosciences Resumes Trading on the Nasdaq Capital Market

September 15, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

August 14, 2025

From Spruce Biosciences, Inc.

Via Business Wire

Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B (MPS IIIB)

August 14, 2025

From Spruce Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.